» Articles » PMID: 31789389

UNC5C‑knockdown Enhances the Growth and Metastasis of Breast Cancer Cells by Potentiating the Integrin α6/β4 Signaling Pathway

Overview
Journal Int J Oncol
Specialty Oncology
Date 2019 Dec 3
PMID 31789389
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Unc‑5 Netrin Receptor C (UNC5C) is a netrin‑1 dependence receptor that mediates the induction of apoptosis in the absence of netrin‑1. The present study found that UNC5C is heterogeneously expressed in breast cancer cell lines. By knocking down UNC5C in SK‑BR‑3 and ZR‑75‑30 cells and overexpressing UNC5c in MDA‑MB‑231 cells, it was demonstrated that UNC5C exerts an inhibitory effect on the growth and metastasis of breast cancer cells. The mechanism involved a UNC5C‑knockdown‑induced enhancement of matrix metalloproteinase (MMP)3, MMP7, MMP9 and MMP10 expression via activation of the PI3K/AKT, ERK and p38 MAPK signaling pathways. Notably, UNC5C directly interacted with integrin α6, which is involved in the growth and metastasis of breast cancer cells. Additionally, UNC5C‑knockdown enhanced the phosphorylation of FAK and SRC, which are key kinases in the netrin‑1/Unc5C and netrin‑1/integrin α6/β4 signaling pathways. This suggests that netrin‑1 functions as an integrator for both the netrin‑1/Unc5C and netrin‑1/integrin α6/β4 signaling pathways. UNC5C‑knockdown potentiated netrin‑1/integrin α6/β4 signaling. Given that UNC5C‑knockdown inhibited integrin‑liked protein kinase phosphorylation at Thr‑173, at least in SK‑BR‑3 cells, this may be an inhibitory phosphorylation site rather than activating phosphorylation site for relaying integrin signaling.

Citing Articles

Bufotalin Induces Oxidative Stress-Mediated Apoptosis by Blocking the ITGB4/FAK/ERK Pathway in Glioblastoma.

Tan J, Lin G, Zhang R, Wen Y, Luo C, Wang R Antioxidants (Basel). 2024; 13(10).

PMID: 39456433 PMC: 11505062. DOI: 10.3390/antiox13101179.


Netrin-1 signaling pathway mechanisms in neurodegenerative diseases.

Zhu K, Wang H, Ye K, Chen G, Zhang Z Neural Regen Res. 2024; 20(4):960-972.

PMID: 38989931 PMC: 11438344. DOI: 10.4103/NRR.NRR-D-23-01573.


Drug resistance‑related gene targets and molecular mechanisms in the A2780/Taxol‑resistant epithelial ovarian cancer cell line.

Yang R, Zhang H, Chen Z, Zhang T, Wei P, Liang H Oncol Lett. 2024; 27(5):232.

PMID: 38586210 PMC: 10996034. DOI: 10.3892/ol.2024.14365.


Research progress of the netrins and their receptors in cancer.

Gao X, Ye J, Huang X, Huang S, Luo W, Zeng D J Cell Mol Med. 2024; 28(8):e18241.

PMID: 38546656 PMC: 10977403. DOI: 10.1111/jcmm.18241.


: Novel Gene Associated with Psychiatric Disorders Impacts Dysregulation of Axon Guidance Pathways.

Treccarichi S, Failla P, Vinci M, Musumeci A, Gloria A, Vasta A Genes (Basel). 2024; 15(3).

PMID: 38540364 PMC: 10970690. DOI: 10.3390/genes15030306.


References
1.
Mao M, Alavi M, Labelle-Dumais C, Gould D . Type IV Collagens and Basement Membrane Diseases: Cell Biology and Pathogenic Mechanisms. Curr Top Membr. 2015; 76:61-116. DOI: 10.1016/bs.ctm.2015.09.002. View

2.
Bhatia V, Mula R, Weigel N, Falzon M . Parathyroid hormone-related protein regulates cell survival pathways via integrin alpha6beta4-mediated activation of phosphatidylinositol 3-kinase/Akt signaling. Mol Cancer Res. 2009; 7(7):1119-31. PMC: 2755566. DOI: 10.1158/1541-7786.MCR-08-0568. View

3.
Chisholm A, Tessier-Lavigne M . Conservation and divergence of axon guidance mechanisms. Curr Opin Neurobiol. 1999; 9(5):603-15. DOI: 10.1016/S0959-4388(99)00021-5. View

4.
Perou C, Sorlie T, Eisen M, van de Rijn M, Jeffrey S, Rees C . Molecular portraits of human breast tumours. Nature. 2000; 406(6797):747-52. DOI: 10.1038/35021093. View

5.
Koch A, Mathivet T, Larrivee B, Tong R, Kowalski J, Pibouin-Fragner L . Robo4 maintains vessel integrity and inhibits angiogenesis by interacting with UNC5B. Dev Cell. 2011; 20(1):33-46. DOI: 10.1016/j.devcel.2010.12.001. View